11:18

A different approach to obesity treatment, with Steffen-Sebastian Bolz

19:37

The importance of being disruption ready, with Brandon Pence

34:04

FH25: Commercialising Health Tech and Deeptech, with Pilar Fernández Hermida

06:26

Why Regeneron is giving away sequencing “for free”, with Alison Fenney

11:58

Agentic AI, culture shifts, and commercialisation today: Anthony Cilento post-Axtria Ignite 2025

11:52

News and advice from an investor-CEO, with Milenko Cicmil

19:28

FH25: On patient access and equity, with Roberta Sarno

11:26

FH25: On healthcare innovation with Gary Monk

06:44

Driving innovation through partnership at AstraZeneca, with Nikhil Mutyal

14:42

The right AI for the right job, with Iya Khalil

11:04

FH25: The art of connection at Frontiers Health with Aline Noizet

35:42

Policy in Focus: Trump’s Most Favoured Nations drug pricing scheme – with Alice Valder Curran

12:55

FH25: Exploring the intersection of patients, HCPs, and technology with Denise Silber

06:15

Axtria Ignite 2025: Ritesh Mehra Talks AI, Culture, and Commercial Change in Life Sciences

10:40

Doing good in people’s lives: Amy Burroughs discusses CML

09:13

FH25: Individual centric investing with Steve Seuntjens

17:18

Pharma and health advertising: Brian Coane on the necessity of humour

26:11

The glimmer of opportunity behind the storm: Ali Pashazadeh talks biotech investment

10:12

FH25: The intersection of tech, science & design with Unity Stoakes

23:34

Changing the drug development treatment paradigm: Hilary Eaton on AI and LLMs

17:02

Increasing trial efficiency: Adityo Prakash talks small datasets, real-world scenarios, and organ...

13:01

FH25: Ten years at the forefront of health innovation, with Kristin Milburn

15:58

MAPs, EAPs, and patient access: Suzanne Aitken on the challenges for pharma

35:43

Weighing in on GLP-1 drugs

11:15

From prostate cancer to breast cancer: In conversation with Christine Roth

26:35

The TechBio way: Brendan Frey talks genomics, AI, and RNA

04:57

Axtria Ignite 2025: Madhavi Ramakrishna on leadership, culture, and AI transformation

08:42

Advancing the frontier of cancer diagnostics: Post-ASCO with Eric Matthews

12:41

Exploring the unconventional to provide hope: Dr Jason Williams at ASCO 2025

19:19

Compliance baked into the design core: On AI in life sciences with Florian Schnappauf

16:51

HLTH Europe: What drives strong pharma-tech collabs

18:41

Putting patients and their families first: Dr Corina Dutcus, post-ASCO 2025

14:09

WeightWatchers’ Scott Honken on rethinking success in the age of GLP-1s

28:20

Enhancing anti-tumour activity: A post-ASCO conversation with Dan Schmitt

01:04:55

The Future of Pharma Marketing – A pharmaphorum executive roundtable

04:58

The gamechanging potential of agentic AI: In conversation with Mark Montgomery at Axtria Ignite 2025

19:06

Redefining the Future of Melanoma Treatment: Scancell's Bold Step Forward

04:33

Following science to fruition, putting patients first: An ASCO25 conversation with AstraZeneca

30:41

Why Datavant bought Aetion, and what comes next, with Arnaub Chatterjee

21:25

Post-ASCO 25: Pamela Tenaerts on CGTs and digital-first long-term follow-up

08:07

Global unity in the face of uncertainty, with Paul Romness and Farah Ahmad

11:18

Taking chemotherapy directly to skin lesions, with Dr Raza Bokhari, Medicus Pharma

25:03

Immune mediation, B-cell depletion, and female leadership – with Aoife Brennan

16:06

Johnson & Johnson at ASCO 2025: Redefining Global Cancer Care Through Bold Data & Vision

15:27

Ben Sidders on integrating causality in AI for R&D success

23:03

Chaos and opportunity: Dr Adam Brown unpacks US health policy

25:33

On nuclear medicine and oncology, SHINE technologies

15:31

Liver cancer diagnostic gets FDA breakthrough status, with Pierre Arséne, Mursla Bio

01:04:17

Unicorns, AI, and the future of health: Highlights from HLTH Europe 2025

18:30

Turning innovative science into value for patients: Astellas at ASCO 2025

08:27

In pursuit of a cure for cancer: An ASCO 2025 discussion with Dr Danny Nguyen

16:34

On patient-centric treatment decisions and the value of quantitative methodologies, in conversati...

09:13

Asking the right questions around AI, with Brian Alexander, Valo Health

13:39

Biotech opportunities in North Carolina, with Kyle Touchstone and Laura Rowley

13:41

Maximising value by uniting the digital backbone: On a new Novo Nordisk and Veeva partnership

06:19

The Leukemia & Lymphoma Society at ASCO 2025: Blood cancers and future oncological trends

06:18

Axtria Ignite 2025: Jaswinder Chadha on Driving Life Sciences Innovation with Agentic AI

09:11

‘Insulin for muscle’ and the AI platform behind it, with Hanadie Yousef

13:57

Merck at ASCO 2025: Cancer is a constellation of many rare diseases, one might say

09:08

A regenerative approach to Alzheimer’s treatment, with Dr. Joshua Hare